According to THE SAGE GROUP, Less Than 20% of Symptomatic Peripheral Artery Disease (PAD) Patients Are Revascularized

BEAUFORT, S.C.--(BUSINESS WIRE)--Recent research published by THE SAGE GROUP examined the number of PAD patients undergoing surgical bypass and endovascular revascularization in the U.S.

“Although PAD remains underdiagnosed and undertreated, the fact that such a small percentage of symptomatic patients are revascularized is surprising,” stated Mary L. Yost, President of THE SAGE GROUP.

“Over the last 30 years, technological innovations have enabled more patients to be treated with the less-invasive endovascular approach. Reflecting the shift away from bypass surgery, endovascular currently accounts for the majority of all PAD revascularizations,” Yost explained.

“However, critical limb ischemia (CLI) patients still undergo surgery more frequently than those with intermittent claudication (IC),” she added.

Regarding the number of endovascular procedures performed by vascular territory Ms. Yost observed, “Due to the different patterns of disease, the territories intervened on differ significantly between patients with IC and CLI.”

“Because CLI is a multilevel disease with more involvement in the below-the-knee territory, these patients undergo a much higher percentage of revascularizations in the infrapopliteal arteries and a lower percentage in the aortoiliac arteries. In IC patients, the opposite is the case. The percentage of endovascular interventions in the femoropopliteal territory is similar for IC and CLI patients,” Yost explained.

PAD is characterized by a reduction of blood flow to the lower limbs due to atherosclerosis. In CLI, or ‘end-stage’ PAD, blood flow is so inadequate that rest pain, ulcers or gangrene occur. Within 5 years, approximately 70% of CLI patients die. Mortality exceeds that of coronary artery disease, breast cancer and colorectal cancer.

About the Report: Peripheral Artery Disease: United States Endovascular Procedure Market by Disease Severity and Vascular Territory Aortoiliac, Femoropopliteal and Infrapopliteal 2015-2040

This report estimates the number of PAD patients and limbs undergoing endovascular revascularization in the U.S. Procedures are estimated separately for CLI and IC. Procedures are estimated by vascular territory in the aortoiliac, femoropopliteal and infrapopliteal locations.

Additional information: Peripheral Artery Disease: United States Endovascular Procedure Market by Disease Severity and Vascular Territory Aortoiliac, Femoropopliteal and Infrapopliteal 2015-2040 - The Sage Group

THE SAGE GROUP, a research and consulting company, specializes in arterial and venous disease in the lower limbs.

Additional information: www.thesagegroup.us.